Elysium Health is a manufacturer of dietary supplements based in New York City. The company released its first product—called Basis—to the public in 2015. Elysium Health is currently researching other supplements, dedicated to cognitive health, skin health, and muscle function.
Basis is made from two primary ingredients: pterostilbene and nicotinamide riboside. Through clinical trials, the combination has been shown to boost levels of NAD+, an essential coenzyme for many cellular functions that decreases in levels as people age.
The Beginnings of Elysium Health
Dr. Leonard Guarente, the director of The Paul F. Glenn Center for the Biology of Aging at the Massachusetts Institute of Technology, came up with the idea to establish Elysium Health several years before the company’s eventual founding.
After Dr. Guarente found suitable business partners in Dan Alminana and Eric Marcotulli, the trio put the proverbial pen to paper and created Elysium Health in 2014.
At first, Elysium Health studied several products but decided to focus on taking Basis to market. Although the ingredients in Basis have been used in dietary supplements for decades prior, the combination had never been combined together in a supplement before.
The Science Behind Basis, Elysium Health’s Flagship Dietary Supplement
A clinical trial involving daily intake of Basis for at least four weeks in a row was found to raise NAD+ levels in humans by an average of 40 percent. The study’s results were published in late November of 2017 in the academic journal npj: Aging and Mechanisms of Disease.
Elysium Health sells Basis in individual jars (each one containing a 30-day supply of the supplement) or as monthly subscriptions. An individual jar costs $60, but the monthly subscriptions to Basis bring the cost down to between $40-50 a month, depending on the length of the subscription.